Does Spironolactone Cause Weight Gain? The Scale Might Actually Tip the Other Way
That's a notably clean signal for a medication many people worry about. If you've been prescribed spironolactone and Googled the side effects list, you may have seen "weight gain" mentioned. The clinical evidence tells a different story.
What the Largest Trial Found
The strongest data comes from the TOPCAT trial, which followed 1,767 patients with a type of heart failure called HFpEF (heart failure with preserved ejection fraction). Patients on spironolactone lost a small amount of weight, roughly 0.5 kg (about 1 pound), in the first 8 to 12 months.
More striking: spironolactone reduced the odds of gaining 5% or more of body weight in that first year, with an odds ratio of 0.58. In plain terms, patients taking spironolactone were about 42% less likely to have a meaningful weight increase compared to those on placebo.
Over the long term, the difference faded. Both groups ended up at about 1% below their starting weight. So spironolactone didn't produce lasting weight loss, but it certainly didn't cause gain either.
Women With PCOS or Acne: No Signal for Gain
Spironolactone is commonly prescribed to women for hormonal acne and polycystic ovary syndrome (PCOS), often at 100 mg per day. Multiple 12-month trials in these populations found no systematic weight gain from the drug.
In obese women specifically, weight changes tracked with diet and lifestyle choices, not with spironolactone use. The drug was essentially neutral on the scale.
Side effect lists for spironolactone do mention increased appetite and body weight as possible occurrences. But in the actual study cohorts, this was not observed and is described as uncommon.
A Subtle Effect on Fat Distribution, Not Total Weight
One finding worth noting: in obese postmenopausal women following a calorie-restricted diet, spironolactone did not increase total weight. However, it was associated with slightly less loss of subcutaneous fat compared to placebo or other treatments.
This is a nuance about where fat sits, not about how much you weigh. And in patients with primary aldosteronism (a condition of excess aldosterone), spironolactone did not significantly change body fat percentage or muscle mass compared to another medication in the same class.
The Evidence at a Glance
| Population | Effect on Weight | Key Detail |
|---|---|---|
| Heart failure (TOPCAT, 1,767 patients) | Small early loss, no long-term gain | ~0.5 kg lost in first 8–12 months; 42% lower odds of gaining ≥5% body weight |
| PCOS / acne (100 mg/day, 12 months) | No consistent change | Diet and lifestyle drove any weight shifts, not the drug |
| Obese postmenopausal women (dieting) | No gain | Subtle differences in fat distribution only |
| Primary aldosteronism | No change | No shift in body fat percentage or muscle mass |
If You're Worried About the Scale
The research here is unusually consistent. Spironolactone does not cause weight gain in any studied population. If anything, it slightly favors weight loss in the short term for certain cardiovascular patients, and it holds steady everywhere else.
Could a rare individual experience increased appetite or modest gain? The research acknowledges this is possible but emphasizes it is not the typical pattern. If you notice unexpected weight changes on spironolactone, diet, activity, and other medications are far more likely explanations than the spironolactone itself.
